Avalon Globocare Corp. has announced a new partnership with Qi Diagnostics Limited to co-develop a real-time cannabis breathalyzer aimed at detecting potential impaired driving. The agreement will see both companies collaborate on designing, validating, and developing a prototype of the device, which utilizes VOC nanosensor technology. This device is intended to enhance public safety by providing law enforcement and workplaces with a non-invasive tool for detecting cannabis impairment. David Jin, President and CEO of Avalon GloboCare, emphasized the significance of this collaboration in advancing Avalon's mission to offer innovative diagnostic solutions that impact public health and safety.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.